PSTI Overview
Upcoming Projects (PSTI)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (PSTI)
-
Analyzing Recent Developments in Induced Pluripotent Stem Cell Therapy
Tickers: PSTI, VRTX, Healios KK, 4593:Tokyo
Execute By: Nov 30, 2021
Upcoming & Overdue Catalysts (PSTI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PSTI)
-
Top-Line Phase 2 Results from Pluristem's (PSTI) Trial Evaluating PLX-PAD in Intermittent Claudication Due Early 2018
Ticker: PSTI
Occurred on: Jun 12, 2018 -
Pluristem (PSTI) Completes Enrollment in Phase 2 Trial Evaluating PLX-PAD in Intermittent Claudication
Ticker: PSTI
Occurred on: Jan 12, 2017 -
Pluristem Advances Towards Multinational Phase III Trial of PLX-PAD to Improve Recovery Following Surgery for Hip Fracture
Ticker: PSTI
Occurred on: Jul 27, 2016 -
Data from Pluristem's PLX-PAD Cells Animal Model to be Released in H1 of 2016
Ticker: PSTI
Occurred on: Jun 22, 2016 -
Pluristem Cleared by FDA to Begin Phase 1 Trial of PLX-R18 Cells for Treatment of Incomplete Hematopoietic Recovery
Ticker: PSTI
Occurred on: Feb 16, 2016
Strategic Initiatives (PSTI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
